The New York-based AI biotech will use its AMICA-OS platform to analyze clinical immune data for BMS, aiming to inform patient stratification, biomarkers, and trial decisions.
Dawnguard and Invictus Incident Response forge strategic partnership to redefine cloud security and resilience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback